Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Recruiting · NCT07060547 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver disease, hepatitis, liver disorder, substance-related disorder | Recruiting | Not stated | 2026-09-16 | NCT07060547 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| HepQuant, LLC | 4 |
| Leland Stanford Junior University | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Stanford University Dept. of Medicine -Gastroenterology & Hepatology | Redwood City | United States | 1 |